Skip to content
OpenCapital
Get started

Korro Bio, Inc. KRRO Q1 2026 earnings

Reported May 7, 2026 · Before market open

EPS-$1.69Miss by $0.09
Revenue estimate$761.2K
EPS estimate-$1.60

Next report

Aug 11, 2026 (In 1 week)
Revenue estimate$214.3K
EPS estimate-$1.34

Versus estimates

Revenue

Q4 2025$1.3MBeat by $600.0KQ3 2025$1.1MBeat by $665.0KQ2 2025$1.5MBeat by $1.1MQ1 2025$2.6MBeat by $2.1MQ4 2024$2.3M

Diluted EPS

Q1 2026-$1.69Miss by $0.09
Q4 2025-$5.32Miss by $3.39Q3 2025-$1.92Beat by $0.69Q2 2025-$2.74Miss by $0.20Q1 2025-$2.49Beat by $0.11Q4 2024-$2.26Beat by $0.07

Ask the moment Korro Bio, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Korro Bio, Inc. report Q1 2026 earnings?
Korro Bio, Inc. (KRRO) reported Q1 2026 earnings on May 7, 2026 before market open.
What were Korro Bio, Inc.'s Q1 2026 revenue and EPS?
Korro Bio, Inc. reported eps of $-1.69 for Q1 2026.
Did Korro Bio, Inc. beat estimates in Q1 2026?
EPS missed the consensus estimate of $-1.60 by $0.09.
How did Korro Bio, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 32.1% from $-2.49.
Where can I find Korro Bio, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-210291) and the 10-Q periodic report (0001193125-26-210303) directly on SEC EDGAR. The filing index links above go to sec.gov.